Northsight Capital plans to acquire Stargreen Holdings to expand its business and presence in the cannabis industry.

Based on the purchase consideration, Northsight expects the acquisition to cost between $5m and $20m.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all
"Based on the purchase consideration, Northsight expects the acquisition to cost between $5m and $20m."

The company will issue 210 million of its common stock shares to raise funds for the acquisition.

GL Capital Management and ABG Management plan to acquire SciClone Pharma for a purchase consideration of $570m.

The companies plan to fund the acquisition through debt and equity financing.

Morgan Stanley is acting as transaction adviser, and Skadden Arps, Slate Meagher &Flom and Fangda Law Firm are acting as legal advisers for the acquisition.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Tonghua Golden Horse Pharmaceutical Industry plans to acquire medicinal materials firm Lhasa.

The company expects the acquisition to cost up to $1.6m.